Skip to Content
MilliporeSigma

Key Documents

View All Documentation

Skip To

SML2102

GSK256066

Synonym(s):

6-({3-[(Dimethylamino)carbonyl]phenyl}sulfonyl)-8-methyl-4-{[3-(methoxy)phenyl]amino}-3-quinolinecarboxamide, 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide, GSK 256066, GSK-256066

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Size/SKUAvailabilityPrice
5 mg
Please contact Customer Service for Availability
$125.00
$106.25
25 mg
Please contact Customer Service for Availability
$506.00
$430.10

About This Item

Empirical Formula (Hill Notation):
C27H26N4O5S
CAS Number:
801312-28-7
Molecular Weight:
518.58
UNSPSC Code:
51111800
MDL number:
MFCD18206923
NACRES:
NA.21
Assay:
≥97% (HPLC)
Form:
powder

$106.25

List Price$125.00Save 15%
Web-Only Promotion
Please contact Customer Service for Availability
​
Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

assay

≥97% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

−20°C

SMILES string

[S](=O)(=O)(c4cc(ccc4)C(=O)N(C)C)c1cc2c([nH]cc([c]2=Nc3cc(ccc3)OC)C(=O)N)c(c1)C

InChI

1S/C27H26N4O5S/c1-16-11-21(37(34,35)20-10-5-7-17(12-20)27(33)31(2)3)14-22-24(16)29-15-23(26(28)32)25(22)30-18-8-6-9-19(13-18)36-4/h5-15H,1-4H3,(H2,28,32)(H,29,30)

InChI key

JFHROPTYMMSOLG-UHFFFAOYSA-N

Biochem/physiol Actions

GSK256066 is a reversible and cAMP-competitive phosphodiesterase 4 (PDE4) inhibitor that targets all PDE4 subtypes with high affinity (IC50 = 53.7 pM against 2 nM [3H]-rolipram for binding HRBS in rat brain cytosol), potency and selectivity (pIC50 ≥11.31/11.5/11.42/11.94 against PDE4A/B/C/D vs. pIC50 = 5.73/5.92/5.93/5.39/5.28/8.11 against PDE1/2/3/5/6/7 by SPA assays). GSK256066 effectively inhibits LPS-induced TNFα production from human whole blood and isolated PBMCs (pIC50 = 126 and 10 pM, respectively) in vitro and acute pulmonary neutrophilia in rats in vivo (ED50 = 1.1 μg/kg, administered intratracheally 2 hrs priror to LPS). GSK256066 is shown to be more potent than Cilomilast (SB-207499) and Roflumilast in both cell-free and cell-based assays.
Highly potent and selective phosphodiesterase 4 (PDE4) inhibitor that inhibits LPS-induced inflammatory response both in cultures and in rats in vivo.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
SML1990S5192SML0895
GSK256066

Sigma-Aldrich

SML2102

GSK256066

GW806742X ≥98% (HPLC)

Sigma-Aldrich

SML1990

GW806742X

SB 222200 ≥98% (HPLC), solid

Sigma-Aldrich

S5192

SB 222200

AGI-6780 ≥98% (HPLC)

Sigma-Aldrich

SML0895

AGI-6780

form

powder

form

powder

form

solid

form

powder

assay

≥97% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

storage temp.

−20°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

solubility

DMSO: 2 mg/mL, clear

solubility

DMSO: 2 mg/mL, clear

solubility

DMSO: soluble ~28 mg/mL, H2O: insoluble

solubility

DMSO: 20 mg/mL, clear

color

white to beige

color

white to beige

color

light yellow

color

white to light brown

Storage Class

11 - Combustible Solids

wgk

WGK 3

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Questions

Reviews

No rating value

Active Filters